[Form 4] PhenixFIN Corp Insider Trading Activity

Rhea-AI Filing Summary

Ellida McMillan, Chief Financial Officer of PhenixFIN Corp (PFX), reported an insider purchase. On 09/23/2025 she acquired 248 shares of PhenixFIN common stock at $47.75 per share, bringing her total beneficial ownership to 3,235 shares. The Form 4 was signed on 09/25/2025. The filing discloses only this non-derivative purchase by the reporting officer and contains no additional transactions or explanatory details.

Positive

• Officer purchase disclosed: The CFO made a direct purchase of 248 shares, increasing her beneficial ownership to 3,235 shares.
• Clear transaction details: The Form 4 specifies date (09/23/2025), price ($47.75), and transaction code (P), meeting disclosure requirements.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchase of 248 shares at $47.75 increases CFO's stake to 3,235 shares.

The Form 4 shows a single non-derivative purchase by Ellida McMillan on 09/23/2025 for 248 shares at $47.75, with post-transaction beneficial ownership of 3,235 shares. The disclosure is factual and limited to the transaction details; no proceeds, sales, option grants, or other equity changes are reported. From a reporting standpoint, this is a routine Section 16 filing documenting an officer purchase.

Corporate Governance Expert

TL;DR: Filing is a standard insider purchase disclosure with clear transaction and ownership figures.

The Form 4 is signed and properly identifies the reporting person, role as Chief Financial Officer, transaction date, transaction code (P), quantity purchased (248), price ($47.75), and resulting beneficial ownership (3,235 shares). The form contains no additional contextual notes or related-party information. As filed, it fulfills disclosure obligations under Section 16 without indicating any material governance events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

McMillan Ellida

(Last) (First) (Middle)

445 PARK AVENUE

10TH FLOOR

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PhenixFIN Corp [ PFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK, $0.001 par value	09/23/2025		P		248	A	$47.75	3,235	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Ellida McMillan	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PhenixFIN (PFX) insider Ellida McMillan report on the Form 4?

The Form 4 reports Ellida McMillan purchased 248 shares of PhenixFIN common stock on 09/23/2025 at $47.75 per share, with beneficial ownership totaling 3,235 shares.

What is Ellida McMillan's role at PhenixFIN (PFX)?

The filing identifies Ellida McMillan as an officer with the title Chief Financial Officer.

When was the Form 4 signed and filed for the PFX transaction?

The signature on the Form 4 is dated 09/25/2025, and the reported transaction date is 09/23/2025.

Does the Form 4 report any derivative transactions or sales for PFX?

No. The Form 4 lists only a non-derivative purchase of common stock and contains no derivative transactions or dispositions.

What transaction code is used on the Form 4 for this PFX purchase?

The transaction is reported with code P, indicating a purchase of shares.